<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of Pharmacy and Health Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPHR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2321-3647</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPHR404006</article-id>
      <title-group>
        <article-title>Design, Synthesis, Characterization and Biological Evaluation of New Heterocyclic Derivatives As Anti-Tubercular Agents</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Suresh</surname>
            <given-names>Ayyadurai Jerad</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lakshmi</surname>
            <given-names>Geetha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saranya</surname>
            <given-names>Sundaralingam</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Surya</surname>
            <given-names>Parakkot Ramakrishnan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">College of Pharmacy, Madras Medical College, Chennai</aff>
      <pub-date pub-type="epub" iso-8601-date="2016-04-01">
        <month>04</month>
        <day>01</day>
        <year>2016</year>
      </pub-date>
      <volume>4</volume>
      <issue>4</issue>
      <abstract>
        <p>Oxadiazole, a heterocyclic nucleus has attracted a wide attention of the chemist in search for the new therapeutic molecules. Some of the recent studies show that oxadiazole are reported to possess an anti-tubercular, anti-epileptic, analgesic, hypnotic, and sedative activity.1 Catechol is a chemical, but a catechol may also be used as the name of a substance, where it represents a 1, 2-dihydroxy benzene group2. In the present study 1, 3, 4-oxadiazole and phenyl amino benzene 1,2 -diol derivatives were docked against methoxymycolic acid synthase-2 and synthesized using reflux condensation reaction. The newly synthesized compounds were characterized by elemental and spectral methods. Compounds RSP1, RSP3 and RSP4 are novel compounds. Anti-tubercular activities of these compounds were carried out using Alamar blue assay method and these compounds exhibited good activity. Compound with phenyl amino benzene 1, 2 diol showed good activity and oxadiazole showed moderate activity compared with standard drugs. RSP1, RSP3, and RSP4 shows good activity at the range of 0.8µg -50ng.RSP6 and RSP7 shows activity at 12.5µg. A further refinement to the structure of the synthesized compounds is expected to yield new outlook to the development of promising molecules against Mycobacterium tuberculosis.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Oxadiazole</kwd>
        <kwd>anti-tubercular</kwd>
        <kwd>catechol</kwd>
        <kwd>phenyl amino benzene1</kwd>
        <kwd>2-diol</kwd>
        <kwd>analgesic.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
